Поиск по репозиторию
Статья
Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - Impact of the COVID-19 pandemic
A. Melidou,
D. Pereyaslov,
O. Hungnes,
K. Prosenc,
E. Alm,
C. Adlhoch,
J. Fielding,
M. Sneiderman,
O. Martinuka,
L. Celentano,
R. Pebody,
M. Redlberger-Fritz,
J. Aberle,
R. Trebbien,
J. Nissen,
N. Ikonen,
A. Haveri,
R. Durrwald,
G. Gioula,
M. Exindari,
A. Kossyvakis,
A. Mentis,
L. Dunford,
L. Domegan,
M. Castrucci,
S. Puzelli,
N. Zamjatina,
G. Pakarna,
A. Griskevičius,
A. Skrickiene,
G. Fournier,
J. Mossong,
A. Meijer,
R. Fouchier,
K. Bragstad,
R. Guiomar,
P. Pechirra,
M. Lazar,
C. Maria,
A. Komissarov,
D. Danilenko,
E. Burtseva,
E. Tichá,
E. Staronova,
N. Berginc,
F. Pozo,
I. Casas,
M. Brytting,
A. Gonçalves,
I. Demchyshyna,
A. Lackenby,
C. Thompson,
R. Gunson,
S. Shepherd,
C. Moore,
S. Cottrell,
P. Penttinen,
J. McCauley,
R. Daniels,
2020
The COVID-19 pandemic negatively impacted the 2019/20 WHO European Region influenza surveillance. Compared with previous 4-year averages, antigenic and genetic characterisations decreased by 17% (3,140 vs 2,601) and 24% (4,474 vs 3,403). Of sub-typed influenza A viruses, 56% (26,477/47,357) were A(H1)pdm09, 44% (20,880/47,357) A(H3). Of characterised B viruses, 98% (4,585/4,679) were B/Victoria. Considerable numbers of viruses antigenically differed from northern hemisphere vaccine components. In 2020/21, maintaining influenza virological surveillance, while supporting SARS-CoV-2 surveillance is crucial.
Цитирование
Похожие публикации
T. Meerhoff,
A. Simaku,
D. Ulqinaku,
G. Spiteri,
J. Fielding,
M. Diercke,
C. Adlhoch,
P. Mook,
F. Lamb,
Версии
- 1. Version of Record от 2020-11-01
Метаданные
Об авторах
-
A. Melidou
European Centre for Disease Prevention and Control -
D. Pereyaslov
WHO Regional Office for Europe -
O. Hungnes
Norwegian Institute of Public Health -
K. Prosenc
National Laboratory of Health -
E. Alm
European Centre for Disease Prevention and Control -
C. Adlhoch
European Centre for Disease Prevention and Control -
J. Fielding
WHO Regional Office for Europe -
M. Sneiderman
WHO Regional Office for Europe -
O. Martinuka
European Centre for Disease Prevention and Control -
L. Celentano
European Centre for Disease Prevention and Control -
R. Pebody
WHO Regional Office for Europe -
M. Redlberger-Fritz
Medizinische Universitat Wien -
J. Aberle
Medizinische Universitat Wien -
R. Trebbien
Statens Serum Institut -
J. Nissen
Statens Serum Institut -
N. Ikonen
Finnish Institute for Health and Welfare -
A. Haveri
Finnish Institute for Health and Welfare - R. Durrwald
-
G. Gioula
National Influenza Centre for Northern Greece -
M. Exindari
National Influenza Centre for Northern Greece -
A. Kossyvakis
Institute Pasteur Hellenique -
A. Mentis
Institute Pasteur Hellenique -
L. Dunford
University College Dublin -
L. Domegan
Health Protection Surveillance Centre -
M. Castrucci
Istituto Superiore Di Sanita -
S. Puzelli
Istituto Superiore Di Sanita -
N. Zamjatina
National Influenza Centre for Latvia -
G. Pakarna
National Influenza Centre for Latvia -
A. Griskevičius
National Public Health Surveillance Laboratory -
A. Skrickiene
Centre for Communicable Diseases and AIDS -
G. Fournier
National Public Health Laboratory Luxembourg -
J. Mossong
National Public Health Laboratory Luxembourg -
A. Meijer
National Institute for Public Health and the Environment -
R. Fouchier
Erasmus MC -
K. Bragstad
Norwegian Institute of Public Health -
R. Guiomar
Instituto Nacional de Saúde Dr. Ricardo Jorge -
P. Pechirra
Instituto Nacional de Saúde Dr. Ricardo Jorge -
M. Lazar
'Cantacuzino' National Medico-Military Institute for Research and Development -
C. Maria
'Cantacuzino' National Medico-Military Institute for Research and Development -
A. Komissarov
Ministry of Health of Russian Federation -
D. Danilenko
Smorodintsev Research Institute of Influenza -
E. Burtseva
Ministry of Health of Russian Federation -
E. Tichá
National Influenza Centre for -
E. Staronova
National Influenza Centre for -
N. Berginc
National Laboratory for Health -
F. Pozo
Instituto de Salud Carlos III -
I. Casas
Instituto de Salud Carlos III -
M. Brytting
Public Health Agency of Sweden -
A. Gonçalves
Hôpitaux Universitaires de Genève -
I. Demchyshyna
National Influenza Centre for Ukraine -
A. Lackenby
Public Health England -
C. Thompson
Public Health England -
R. Gunson
West of Scotland Specialist Virology Centre -
S. Shepherd
West of Scotland Specialist Virology Centre -
C. Moore
Public Health Wales -
S. Cottrell
Public Health Wales -
P. Penttinen
European Centre for Disease Prevention and Control -
J. McCauley
The Francis Crick Institute -
R. Daniels
The Francis Crick Institute
Название журнала
- Eurosurveillance
Том
- 25
Выпуск
- 46
Финансирующая организация
- World Health Organization
Номер гранта
- 40/2019
Тип документа
- journal article
Тип лицензии Creative Commons
- CC BY
Правовой статус документа
- Свободная лицензия
Источник
- scopus
